{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:35Z","timestamp":1787020655577,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82471499"],"award-info":[{"award-number":["82471499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangxi Key Laboratory of Neurological Diseases","award":["2024SSY06072"],"award-info":[{"award-number":["2024SSY06072"]}]},{"name":"the startup package and developmental funds of the First Affiliated Hospital of Nanchang University","award":["500021001 and 500021002"],"award-info":[{"award-number":["500021001 and 500021002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03545-w","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:21:44Z","timestamp":1759407704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cerebrospinal fluid neuronal pentraxin levels are associated with tau pathology via microglia\u2013astrocyte signaling in alzheimer\u2019s disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Zihao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Quan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"2","key":"3545_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312\u201339.","journal-title":"Cell"},{"key":"3545_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jare.2023.01.006","volume":"54","author":"FJ Rodriguez-Jimenez","year":"2023","unstructured":"Rodriguez-Jimenez FJ, Ure\u00f1a-Peralta J, Jendelova P, Erceg S. Alzheimer\u2019s disease and synapse loss: what can we learn from induced pluripotent stem cells?? J Adv Res. 2023;54:105\u201318.","journal-title":"J Adv Res"},{"issue":"2","key":"3545_CR3","doi-asserted-by":"publisher","first-page":"fcac083","DOI":"10.1093\/braincomms\/fcac083","volume":"4","author":"R Mart\u00ednez-Serra","year":"2022","unstructured":"Mart\u00ednez-Serra R, Alonso-Nanclares L, Cho K, Giese KP. Emerging insights into synapse dysregulation in alzheimer\u2019s disease. Brain Commun. 2022;4(2):fcac083.","journal-title":"Brain Commun"},{"issue":"2","key":"3545_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00702-021-02411-2","volume":"129","author":"N de G\u00f3mez","year":"2021","unstructured":"de G\u00f3mez N, Massa F, Halbgebauer S, Oeckl P, Steinacker P, Otto M. Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration. J Neural Transm. 2021;129(2):207\u201330.","journal-title":"J Neural Transm"},{"issue":"2","key":"3545_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00702-021-02411-2","volume":"129","author":"N de G\u00f3mez","year":"2022","unstructured":"de G\u00f3mez N, Massa F, Halbgebauer S, Oeckl P, Steinacker P, Otto M. Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration. J Neural Transm (Vienna). 2022;129(2):207\u201330.","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"3545_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/jnnp-2019-322493","volume":"91","author":"EL van der Ende","year":"2020","unstructured":"van der Ende EL, Xiao M, Xu D, Poos JM, Panman JL, Jiskoot LC, Meeter LH, Dopper EG, Papma JM, Heller C, et al. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2020;91(6):612\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3545_CR7","doi-asserted-by":"crossref","unstructured":"Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D et al: NPTX2 and cognitive dysfunction in Alzheimer's Disease. Elife. 2017;6:e23798.","DOI":"10.7554\/eLife.23798"},{"issue":"4","key":"3545_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/ana.26725","volume":"94","author":"A Soldan","year":"2023","unstructured":"Soldan A, Oh S, Ryu T, Pettigrew C, Zhu Y, Moghekar A, Xiao MF, Pontone GM, Albert M, Na CH, et al. NPTX2 in cerebrospinal fluid predicts the progression from normal cognition to mild cognitive impairment. Ann Neurol. 2023;94(4):620\u201331.","journal-title":"Ann Neurol"},{"key":"3545_CR9","doi-asserted-by":"crossref","unstructured":"Oh HS, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, Timsina J, Duggan MR, Chen J, Guldner IH et al: A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's disease. Nat Med. 2025;31(5):1592\u20131603.","DOI":"10.1038\/s41591-025-03565-2"},{"issue":"49","key":"3545_CR10","doi-asserted-by":"publisher","first-page":"12735","DOI":"10.1523\/JNEUROSCI.0575-06.2006","volume":"26","author":"MA Abad","year":"2006","unstructured":"Abad MA, Enguita M, DeGregorio-Rocasolano N, Ferrer I, Trullas R. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in alzheimer\u2019s brain. J Neurosci. 2006;26(49):12735\u201347.","journal-title":"J Neurosci"},{"key":"3545_CR11","doi-asserted-by":"crossref","unstructured":"Zhou J, Wade SD, Graykowski D, Xiao MF, Zhao B, Giannini LAA, Hanson JE, van Swieten JC, Sheng M, Worley PF et al: The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci Transl Med. 2023;15(689):eadf0141.","DOI":"10.1126\/scitranslmed.adf0141"},{"key":"3545_CR12","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3389\/fimmu.2020.01757","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wang X, Zou H, Dai Z, Feng S, Zhang M, Xiao G, Liu Z, Cheng Q. The basic characteristics of the pentraxin family and their functions in tumor progression. Front Immunol. 2020;11:1757.","journal-title":"Front Immunol"},{"issue":"2","key":"3545_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrneurol.2016.203","volume":"13","author":"H Wood","year":"2017","unstructured":"Wood H. Alzheimer disease: soluble TREM2 in CSF sheds light on microglial activation in AD. Nat Rev Neurol. 2017;13(2):65.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3545_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-023-02843-5","volume":"20","author":"T Liu","year":"2023","unstructured":"Liu T, Zuo H, Ma D, Song D, Zhao Y, Cheng O. Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and alzheimer\u2019s disease-associated biomarkers alterations among de Novo parkinson\u2019s disease patients: a prospective cohort study. J Neuroinflammation. 2023;20(1):167.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"3545_CR15","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, Rezzonico MG, Imperio J, Lalehzadeh G, Huntley MA, et al. Trem2 restrains the enhancement of Tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron. 2021;109(8):1283\u2013e13011286.","journal-title":"Neuron"},{"key":"3545_CR16","doi-asserted-by":"publisher","first-page":"848180","DOI":"10.3389\/fnagi.2022.848180","volume":"14","author":"YH Chen","year":"2022","unstructured":"Chen YH, Lin RR, Huang HF, Xue YY, Tao QQ. Microglial activation, Tau pathology, and neurodegeneration biomarkers predict longitudinal cognitive decline in alzheimer\u2019s disease continuum. Front Aging Neurosci. 2022;14:848180.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3545_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"7\u20138","key":"3545_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/prca.201400178","volume":"9","author":"DS Spellman","year":"2015","unstructured":"Spellman DS, Wildsmith KR, Honigberg LA, Tuefferd M, Baker D, Raghavan N, Nairn AC, Croteau P, Schirm M, Allard R, et al. Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in alzheimer\u2019s disease neuroimaging initiative (ADNI) CSF. Proteom Clin Appl. 2015;9(7\u20138):715\u201331.","journal-title":"Proteom Clin Appl"},{"issue":"4","key":"3545_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, et al. Cerebrospinal fluid biomarker signature in alzheimer\u2019s disease neuroimaging initiative subjects. Ann Neurol. 2009;65(4):403\u201313.","journal-title":"Ann Neurol"},{"issue":"5","key":"3545_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","volume":"12","author":"T Bittner","year":"2016","unstructured":"Bittner T, Zetterberg H, Teunissen CE, Ostlund RE Jr., Militello M, Andreasson U, Hubeek I, Gibson D, Chu DC, Eichenlaub U, et al. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1\u201342) in human cerebrospinal fluid. Alzheimers Dement. 2016;12(5):517\u201326.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"3545_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jalz.2010.03.003","volume":"6","author":"WJ Jagust","year":"2010","unstructured":"Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA. The alzheimer\u2019s disease neuroimaging initiative positron emission tomography core. Alzheimers Dement. 2010;6(3):221\u20139.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3545_CR22","doi-asserted-by":"publisher","first-page":"16097","DOI":"10.1038\/s41598-024-67052-3","volume":"14","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Chen X, Sheng Z. Association of triglyceride glucose-body mass index with alzheimer\u2019s disease pathology, cognition and brain structure in non-demented people. Sci Rep. 2024;14(1):16097.","journal-title":"Sci Rep"},{"issue":"4","key":"3545_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, Jones RN, Mukherjee S, Curtis SM, Harvey D, et al. Development and assessment of a composite score for memory in the alzheimer\u2019s disease neuroimaging initiative (ADNI). Brain Imaging Behav. 2012;6(4):502\u201316.","journal-title":"Brain Imaging Behav"},{"issue":"6","key":"3545_CR24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173\u201382.","journal-title":"J Pers Soc Psychol"},{"issue":"6","key":"3545_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib N, McCabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-Szternfeld R, Green G, Dionne D, Nguyen L, Marshall JL, et al. Disease-associated astrocytes in alzheimer\u2019s disease and aging. Nat Neurosci. 2020;23(6):701\u20136.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3545_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in alzheimer\u2019s disease. Nat Med. 2020;26(1):131\u201342.","journal-title":"Nat Med"},{"key":"3545_CR27","doi-asserted-by":"crossref","unstructured":"Dulewicz M, Kulczy\u0144ska-Przybik A, S\u0142owik A, Borawska R, Mroczko B. Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer\u2019s Disease. J Clin Med 2021;10(19).","DOI":"10.3390\/jcm10194575"},{"key":"3545_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nbd.2018.02.014","volume":"114","author":"QL Ma","year":"2018","unstructured":"Ma QL, Teng E, Zuo X, Jones M, Teter B, Zhao EY, Zhu C, Bilousova T, Gylys KH, Apostolova LG, et al. Neuronal pentraxin 1: A synaptic-derived plasma biomarker in alzheimer\u2019s disease. Neurobiol Dis. 2018;114:120\u20138.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3545_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-020-00398-0","volume":"15","author":"O Belbin","year":"2020","unstructured":"Belbin O, Xiao MF, Xu D, Carmona-Iragui M, Pegueroles J, Benejam B, Videla L, Fern\u00e1ndez S, Barroeta I, Nu\u00f1ez-Llaves R, et al. Cerebrospinal fluid profile of NPTX2 supports role of alzheimer\u2019s disease-related inhibitory circuit dysfunction in adults with down syndrome. Mol Neurodegener. 2020;15(1):46.","journal-title":"Mol Neurodegener"},{"key":"3545_CR30","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.trci.2019.11.002","volume":"5","author":"D Galasko","year":"2019","unstructured":"Galasko D, Xiao M, Xu D, Smirnov D, Salmon DP, Dewit N, Vanbrabant J, Jacobs D, Vanderstichele H, Vanmechelen E, et al. Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and alzheimer\u2019s disease. Alzheimers Dement (N Y). 2019;5:871\u201382.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"3545_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JAD-220318","volume":"90","author":"K Bolsewig","year":"2022","unstructured":"Bolsewig K, Hok-A-Hin YS, Sepe FN, Boonkamp L, Jacobs D, Bellomo G, Paoletti FP, Vanmechelen E, Teunissen CE, Parnetti L, et al. A combination of neurofilament light, glial fibrillary acidic protein, and neuronal Pentraxin-2 discriminates between frontotemporal dementia and other dementias. J Alzheimers Dis. 2022;90(1):363\u201380.","journal-title":"J Alzheimers Dis"},{"key":"3545_CR32","doi-asserted-by":"crossref","unstructured":"Das S, Goossens J, Jacobs D, Dewit N, Pijnenburg YAL, In 't Veld S, Teunissen CE, Vanmechelen E: Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer's disease and frontotemporal dementia. Alzheimers Res Ther. 2023;15(1):62.","DOI":"10.1186\/s13195-023-01212-x"},{"issue":"689","key":"3545_CR33","doi-asserted-by":"publisher","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wade SD, Graykowski D, Xiao MF, Zhao B, Giannini LAA, Hanson JE, van Swieten JC, Sheng M, Worley PF, et al. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci Transl Med. 2023;15(689):eadf0141.","journal-title":"Sci Transl Med"},{"issue":"3","key":"3545_CR34","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","volume":"22","author":"BA Friedman","year":"2018","unstructured":"Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, Huntley MA, Cao Y, Lee SH, Haddick PCG, Ngu H, et al. Diverse brain myeloid expression profiles reveal distinct microglial activation States and aspects of alzheimer\u2019s disease not evident in mouse models. Cell Rep. 2018;22(3):832\u201347.","journal-title":"Cell Rep"},{"issue":"6","key":"3545_CR35","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of alzheimer\u2019s disease. J Neurochem. 2008;104(6):1433\u20139.","journal-title":"J Neurochem"},{"issue":"4","key":"3545_CR36","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2478\/s13380-013-0144-z","volume":"4","author":"M Jembrek","year":"2013","unstructured":"Jembrek M, Babi\u0107 M, Pivac N, Hof P, \u0160imi\u0107 G. Hyperphosphorylation of Tau by GSK-3\u03b2 in alzheimer\u2019s disease: the interaction of A\u03b2 and sphingolipid mediators as a therapeutic target. Translational Neurosci. 2013;4(4):466\u201376.","journal-title":"Translational Neurosci"},{"issue":"5","key":"3545_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Kleinberger G, Araque Caballero M, Brendel M, Rominger A, Alcolea D, Fortea J, Lle\u00f3 A, Blesa R, Gispert JD, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8(5):466\u201376.","journal-title":"EMBO Mol Med"},{"issue":"7638","key":"3545_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung WS, Peterson TC, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"6","key":"3545_CR39","doi-asserted-by":"publisher","first-page":"fcad286","DOI":"10.1093\/braincomms\/fcad286","volume":"5","author":"F Nabizadeh","year":"2023","unstructured":"Nabizadeh F. sTREM2 is associated with attenuated Tau aggregate accumulation in the presence of amyloid-\u03b2 pathology. Brain Commun. 2023;5(6):fcad286.","journal-title":"Brain Commun"},{"issue":"1","key":"3545_CR40","doi-asserted-by":"publisher","first-page":"15318","DOI":"10.1038\/s41598-024-66211-w","volume":"14","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh F, Seyedmirzaei H, Karami S. Neuroimaging biomarkers and CSF sTREM2 levels in alzheimer\u2019s disease: a longitudinal study. Sci Rep. 2024;14(1):15318.","journal-title":"Sci Rep"},{"issue":"1","key":"3545_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3545_CR42","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/s41467-023-42505-x","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang L, Yang J, Meng L, Chen J, Zhou L, Wang J, Xiong M, Zhang Z. Soluble TREM2 ameliorates Tau phosphorylation and cognitive deficits through activating transgelin-2 in alzheimer\u2019s disease. Nat Commun. 2023;14(1):6670.","journal-title":"Nat Commun"},{"key":"3545_CR43","doi-asserted-by":"crossref","unstructured":"Wu Q, Zou C. Microglial dysfunction in neurodegenerative diseases via RIPK1 and ROS. Antioxid (Basel) 2022, 11(11).","DOI":"10.3390\/antiox11112201"},{"issue":"1","key":"3545_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","volume":"12","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, Holtzman DM. Glial contributions to neurodegeneration in tauopathies. Mol Neurodegener. 2017;12(1):50.","journal-title":"Mol Neurodegener"},{"key":"3545_CR45","doi-asserted-by":"crossref","unstructured":"Han J, Zhang Z, Zhang P, Yu Q, Cheng Q, Lu Z, Zong S. The roles of microglia and astrocytes in neuroinflammation of alzheimer\u2019s disease. Front NeuroSci 2025, 19.","DOI":"10.3389\/fnins.2025.1575453"},{"issue":"1","key":"3545_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42.","journal-title":"Transl Neurodegener"},{"issue":"9","key":"3545_CR47","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1002\/alz.13862","volume":"20","author":"N Warmenhoven","year":"2024","unstructured":"Warmenhoven N, S\u00e1nchez-Benavides G, Gonz\u00e1lez\u2010Escalante A, Mil\u00e0\u2010Alom\u00e0 M, Shekari M, L\u00f3pez\u2010Martos D, Ortiz\u2010Romero P, Kollmorgen G, Quijano\u2010Rubio C, Minguill\u00f3n C, et al. CSF glial biomarkers are associated with cognition in individuals at risk of alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2024;20(9):5819\u201332.","journal-title":"Alzheimer\u2019s Dement"},{"key":"3545_CR48","doi-asserted-by":"crossref","unstructured":"Azzolini F, Gilio L, Pavone L, Iezzi E, Dolcetti E, Bruno A, Buttari F, Musella A, Mandolesi G, Guadalupi L et al: Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis. Biomolecules 2022;12(2):222.","DOI":"10.3390\/biom12020222"},{"key":"3545_CR49","doi-asserted-by":"crossref","unstructured":"Piel JHA, Bargemann L, Leypoldt F, Wandinger KP, Dargvainiene J: Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis. Front Neurol. 2024;15:1356575.","DOI":"10.3389\/fneur.2024.1356575"},{"issue":"3","key":"3545_CR50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3233\/JAD-230199","volume":"95","author":"Y Wu","year":"2023","unstructured":"Wu Y, Eisel ULM. Microglia-Astrocyte communication in alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2023;95(3):785\u2013803.","journal-title":"J Alzheimer\u2019s Disease"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03545-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:03:05Z","timestamp":1759413785000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03545-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3545"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03545-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The entire approval for this study was obtained from the Eisai Ethics Committee (2017\u2009\u2212\u20090433). Following the Declaration of Helsinki, written informed consent was obtained from all participants or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}